Shenzhen New Industries Biomedical Engineering Co. Ltd. Class ASZSE: 300832

Shenzhen New Industries Biomedical Engineering Co: 2024 revenue up 15.41%, net profit up 10.57%, strong global growth and high dividend

· Issued by Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

Revenue grew 15.41% to RMB 4.54 billion, with net profit up 10.57% to RMB 1.83 billion, driven by strong overseas and high-end instrument sales. Gross margin remained high at 72.26%, and a cash dividend of RMB 13 per 10 shares is proposed.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A

All Shenzhen New Industries Biomedical Engineering Co. Ltd. Class A news releases